Home page > Europe and Health | Health, wealth and equity | Health friendly research and innovation | EU Funding and programmes | Irish Presidency priorities


Please find all related articles below.

Council conclusions on Literacy

The Council of the European Union adopted a couple of conclusions on literacy during the 3201st Education, Youth, Culture and Sport Council meeting on 26 and 27 November in Brussels. Levels of literacy remain stagnant in most European countries and one in five European citizens has inadequate literacy levels. Taking into account the fact that literacy is a crucial life competence which empowers the individual citizen and that low literacy levels hold back economic growth and reduces (...)

[Revised EPHA position] Clinical Trials

EPHA has revised its position on clinical trials following the European Commission’s release of a legislative proposal for a regulation over the summer. While the key elements remain the same, the updated version emphasises the need for clinical trials to go ahead so that different population groups can benefit from life-saving treatments, while underlining that patient safety must remain at the centre of the process, and not compromised by less rigid assessment procedures. The (...)

European Innovation Partnership on Active and Healthy Ageing’s conference - Ageing can be an opportunity

The long-awaited First Conference of Partners of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) took place on 6 November in Brussels. One year after the delivery of the Strategic Implementation Plan, the six Action Groups presented their action plans. The conference was an opportunity for stakeholders, already part of an Action Group, to meet and collaborate with different group members, and for more recent stakeholders to have the opportunity to learn about (...)

“Medicine shortages is a global public health problem,” by the Pharmaceutical Group of the European Union

The number of reports of medicine shortages in the EU is increasing. Shortages are occurring across the supply chain and all classes of medicines are affected, from complex chemotherapy agents and anaesthetics to diabetes, hypertension, and asthma medication. This article is a contribution by the Pharmaceutical Group of the European Union (PGEU) There are a number of reasons why some medicines are sometimes unavailable. The medicines supply chain is highly complex and its efficiency (...)

[EPHA Briefing] Criteria for Independent Research

November 2012 - EPHA has produced a briefing on financial conflicts of interest and research in health in light of growing evidence from the tobacco, pharmaceutical and medical fields that the funding source for research may compromise results in favour of commercial interests . In this briefing, EPHA explores if there is a risk that these biases could be extended to nutrition and alcohol science. The purpose of the briefing is to explore academic literature, tools to protect research from (...)

EPHA seminar on General Data Protection

EPHA hosted a seminar on Monday 19 November 2012 to clarify certain elements of the proposal for a revision of the rules on data protection. The European Commission released its revision of the 1995 Data Protection legislation in January of this year, proposing a number of measures which directly affect public health. In order to examine the exact implications for areas such as healthcare, patient protection and medical research, EPHA hosted a seminar clarifying the health matters (...)

Civil Society Contact Group writes to EU Council for an EU Budget that meets peoples’ needs and EU responsabilities

The extraordinary November Summit will focus solely on the EU Budget. Heads of State will defend the budget lines that their countries receive funds from. In this context, members of the Civil Society Contact Group call for a re-prioritisation of EU funds to where they have the biggest impact on the environment, extreme poverty, and people living in Europe. The 22-23 November European Council is a crucial summit for ensuring that the next MFF delivers adequate financing for sustainable (...)

EPHA position on General Data Protection Regulation

EPHA’s position on the General Data Protection Regulation highlights the strengths and weaknesses of the existing proposal from the perspective of the health community and lays out the key provisions in protecting patient safety, individual rights and public health. The European Commission (EC) is currently reviewing its existing legal framework on data protection to ensure that the rules are fit for dealing with increasingly complex and sophisticated developments in technology and (...)

Commission Work programme 2013

On 25 October, the European Commission unveiled its 2013 work programme. Its overarching goal is to put the EU back on the road to sustainable growth. This will entail economic reforms, skills development, research and innovation, and changes in the single market. In the field of health, there are several initiatives mentioned for next year: Review of the Thematic Strategy on air pollution and associated legislation - assess the implementation and achievements of current air pollution (...)

European Health Forum Gastein - 2012 Edition Highlights Austerity Impacts on Health

The 15th European Health Forum Gastein (EHFG) took place between 3-6 October 2012 in Austria. This year’s conference theme was “Crisis and Opportunity – Health in an Age of Austerity’’, and the various plenary sessions, parallel forums and workshops covered topics ranging from health system sustainability to disease prevention, global health governance and the future of public health, research and innovation. In a sense, this year’s EHFG felt like a (...)